Tevogen (TVGN) CEO Saadi Ryan H. Receives 8M Restricted Shares

What Happened

• Saadi Ryan H., Tevogen's CEO, was granted 8,000,000 restricted shares (Transaction code: A) on 2026-09-14. The shares were reported as acquired at $0.00 (total reported value $0) in a Form 4 filed 2026-09-16.

Key Details

• Transaction date: 2026-09-14; Form 4 filed: 2026-09-16 (timely filing).
• Award: 8,000,000 restricted common shares, acquisition price $0.00 (reported value $0).
• Vesting condition: shares vest only if the Board certifies Tevogen has achieved $1.0 billion in aggregate revenue during the performance period from 9/14/2026 through 9/30/2031.
• Forfeiture conditions: automatic forfeiture if the revenue threshold is not met during the performance period, upon termination of the reporting person's service for any reason, for specified misconduct/competitive activity, on transfer/attempted transfer prior to vesting, or if the award is not assumed in a change in control.
• Shares owned after transaction: not specified in the filing.

Context

• This was an award/grant, not a market purchase or sale — there is no immediate cash exchanged and no realized proceeds. The economic benefit depends entirely on meeting the long-term revenue goal and surviving other forfeiture conditions.